Alexandre Couto e Silva

Alexandre Couto e Silva

Auto-generated profile, based on publicly available information

Alexandre Couto e Silva

Oregon Health and Science University Portland Oregon USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Neural Regeneration Research
Verified
Journal Article
Open access
PDF file
HLHung Wen Lin
Hung Wen Lin
RLReggie Hui-Chao Lee
Reggie Hui-Chao Lee
MLMichelle H. H. Lee
Michelle H. H. Lee
CWCeleste Y. C. Wu
Celeste Y. C. Wu
ASAlexandre Couto e Silva
Alexandre Couto e Silva
AMAlireza Minagar
Alireza Minagar
Cerebral ischemia is one of the leading causes of morbidity and mortality worldwide. Although stroke (a form of cerebral ischemia)-related costs are expected to reach 240.67 billion dollars by 2030, options for treatment against cerebral ischemia/stroke are limited. All therapies except anti-thrombolytics (i.e., tissue plasminogen activator) and hypothermia have failed to reduce neuronal injury, neurological deficits, and mortality rates following cerebral ischemia, which suggests that development of novel therapies against stroke/cerebral ischemia are urgently needed. Here, we discuss the possible mechanism(s) underlying cerebral ischemia-induced brain injury, as well as current and future novel therapies (i.e., growth factors, nicotinamide adenine dinucleotide, melatonin, resveratrol, protein kinase C isozymes, pifithrin, hypothermia, fatty acids, sympathoplegic drugs, and stem cells) as it relates to cerebral ischemia.

10 December 2019 in Molecular Neurobiology
Verified
Journal Article
Closed access
PDF file
ASAlexandre Couto e Silva
Alexandre Couto e Silva
CWCeleste Yin-Chieh Wu
Celeste Yin-Chieh Wu
CCCristiane T. Citadin
Cristiane T. Citadin
GCGarrett A. Clemons
Garrett A. Clemons
HPHarLee E. Possoit
HarLee E. Possoit
HLHung Wen Lin
Hung Wen Lin

1 August 2019 in Prostaglandins, Leukotrienes and Essential Fatty Acids
Verified
Journal Article
Closed access
RLReggie Hui-Chao Lee
Reggie Hui-Chao Lee
ASAlexandre Couto e Silva
Alexandre Couto e Silva
HPHarLee E. Possoit
HarLee E. Possoit
FLFrancesca M. Lerner
Francesca M. Lerner
PCPo-Yi Chen
Po-Yi Chen
HLHung Wen Lin
Hung Wen Lin

5 January 2018 in Journal of Visualized Experiments
Verified
Journal Article
Open access
PDF file
CWCeleste Y. C. Wu
Celeste Y. C. Wu
FLFrancesca M. Lerner
Francesca M. Lerner
ASAlexandre Couto e Silva
Alexandre Couto e Silva
HPHarlee E. Possoit
Harlee E. Possoit
THTsung-Han Hsieh
Tsung-Han Hsieh
RLReggie Hui-Chao Lee
Reggie Hui-Chao Lee
Background: Evaluating mild to moderate cognitive impairment in a global cerebral ischemia (i.e. cardiac arrest) model can be difficult due to poor locomotion after surgery. For example, rats who undergo surgical procedures and are subjected to the Morris water maze may not be able to swim, thus voiding the experiment. New Method: We established a modified behavioral spontaneous alternation T-maze test. The major advantage of the modified T-maze protocol is its relatively simple design that is powerful enough to assess functional learning/memory after ischemia. Additionally, the data analysis is simple and straightforward. We used the T-maze to determine the rats' learning/memory deficits both in the presence or absence of mild to moderate (6 min) asphyxial cardiac arrest (ACA). Rats have a natural tendency for exploration and will explore the alternate arms in the T-maze, whereas hippocampal-lesioned rats tend to adopt a side-preference resulting in decreased spontaneous alternation ratios, revealing the hippocampal-related functional learning/memory in the presence or absence of ACA. Results: ACA groups have higher side-preference ratios and lower alternations as compared to control. Comparison with Existing Method(s): The Morris water and Barnes maze are more prominent for assessing learning/memory function. However, the Morris water maze is more stressful than other mazes. The Barnes maze is widely used to measure reference (long-term) memory, while ACA-induced neurocognitive deficits are more closely related to working (short-term) memory. Conclusions: We have developed a simple, yet effective strategy to delineate working (short-term) memory via the T-maze in our global cerebral ischemia model (ACA).

25 August 2021 in Journal of Neurochemistry
Verified
Journal Article
Closed access
PDF file
ASAlexandre Couto E Silva
Alexandre Couto E Silva
CWCeleste Yin-Chieh Wu
Celeste Yin-Chieh Wu
GCGarrett A. Clemons
Garrett A. Clemons
CAChristina H. Acosta
Christina H. Acosta
CCChuck T. Chen
Chuck T. Chen
HLHung Wen Lin
Hung Wen Lin

29 August 2022 in Journal of Cellular Physiology
Verified
Journal Article
Open access
GCGarrett A. Clemons
Garrett A. Clemons
ASAlexandre Couto e Silva
Alexandre Couto e Silva
CAChristina H. Acosta
Christina H. Acosta
MUMariana Sayuri Berto Udo
Mariana Sayuri Berto Udo
VTVesna Tesic
Vesna Tesic
HLHung Wen Lin
Hung Wen Lin
Alzheimer's disease (AD) is the leading cause of mortality, disability, and long‐term care burden in the United States, with women comprising the majority of AD diagnoses. While AD‐related dementia is associated with tau and amyloid beta accumulation, concurrent derangements in cerebral blood flow have been observed alongside these proteinopathies in humans and rodent models. The homeostatic production of nitric oxide synthases (NOS) becomes uncoupled in AD which leads to decreased NO‐mediated vasodilation and oxidative stress via the production of peroxynitrite (ONOO−∙) superoxide species. Here, we investigate the role of the novel protein arginine methyltransferase 4 (PRMT4) enzyme function and its downstream product asymmetric dimethyl arginine (ADMA) as it relates to NOS dysregulation and cerebral blood flow in AD. ADMA (type‐1 PRMT product) has been shown to bind NOS as a noncanonic ligand causing enzymatic dysfunction. Our results from RT‐qPCR and protein analyses suggest that aged (9−12 months) female mice bearing tau‐ and amyloid beta‐producing transgenic mutations (3xTg‐AD) express higher levels of PRMT4 in the hippocampus when compared to age‐ and sex‐matched C57BL6/J mice. In addition, we performed studies to quantify the expression and activity of different NOS isoforms. Furthermore, laser speckle contrast imaging analysis was indicative that 3xTg‐AD mice have dysfunctional NOS activity, resulting in reduced production of NO metabolites, enhanced production of free‐radical ONOO−, and decreased cerebral blood flow. Notably, the aforementioned phenomena can be reversed via pharmacologic PRMT4 inhibition. Together, these findings implicate the potential importance of PRMT4 signaling in the pathogenesis of Alzheimer's‐related cerebrovascular derangement.